Variant report
Variant | nsv8613 |
---|---|
Chromosome Location | chr1:189790453-189805958 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375794050 | chr1:189790487-189790488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs386369098 | chr1:189790488-189790489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373740094 | chr1:189790490-189790491 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201059580 | chr1:189790491-189790492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376982659 | chr1:189790508-189790509 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557191557 | chr1:189790529-189790530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537557735 | chr1:189790547-189790548 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552839100 | chr1:189790555-189790556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs80344483 | chr1:189790588-189790589 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566164336 | chr1:189790628-189790629 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9427457 | chr1:189790657-189790658 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs9427458 | chr1:189790673-189790674 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs557853118 | chr1:189790679-189790680 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188439847 | chr1:189790706-189790707 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572853933 | chr1:189790815-189790816 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9427460 | chr1:189790825-189790826 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs568032727 | chr1:189790851-189790852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549646909 | chr1:189790884-189790885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9427461 | chr1:189790950-189790951 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs116756043 | chr1:189790957-189790958 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10919813 | chr1:189790958-189790959 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs572115615 | chr1:189790969-189790970 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534385545 | chr1:189791015-189791016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34760746 | chr1:189791017-189791018 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368259105 | chr1:189791092-189791093 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558406731 | chr1:189791102-189791103 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576968857 | chr1:189791133-189791134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs578202165 | chr1:189791138-189791139 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4845200 | chr1:189791192-189791193 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs553271761 | chr1:189791214-189791215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs386637871 | chr1:189791218-189791219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143458462 | chr1:189791220-189791221 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543013897 | chr1:189791246-189791247 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559449943 | chr1:189791251-189791252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12138327 | chr1:189791316-189791317 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs147503127 | chr1:189791321-189791322 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563971818 | chr1:189791334-189791335 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532949610 | chr1:189791345-189791346 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560970366 | chr1:189791363-189791364 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs369348997 | chr1:189791371-189791372 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549710191 | chr1:189791383-189791384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569617183 | chr1:189791402-189791403 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs6679329 | chr1:189791416-189791417 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs10919817 | chr1:189791436-189791437 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs555629835 | chr1:189791457-189791458 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565511617 | chr1:189791478-189791479 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534745374 | chr1:189791495-189791496 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566970003 | chr1:189791503-189791504 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560589867 | chr1:189791531-189791532 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557871640 | chr1:189791625-189791626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17899364 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:189789400-189790800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:189789400-189792800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr1:189789800-189790600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr1:189790000-189791600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr1:189790200-189791200 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr1:189790800-189791600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr1:189791200-189791400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr1:189791600-189791800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr1:189801800-189804400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr1:189802000-189803200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr1:189803200-189804000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr1:189804000-189804200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |